A Case Report of Patient with Takayasu's Arteritis Complicated by Reversible Cerebral Vasoconstriction Syndrome.
10.4078/jrd.2013.20.3.194
- Author:
Seung Hoon LEE
1
;
Min Jung LEE
;
Byungju KANG
;
Hyoin CHOI
;
You Jae KIM
;
Bon San KOO
;
Min Wook SO
;
Chang Keun LEE
;
Bin YOO
Author Information
1. Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. cklee@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Takayasu's arteritis;
Reversible cerebral vasoconstriction syndrome
- MeSH:
Basilar Artery;
Brain Ischemia;
Calcium Channels;
Central Nervous System;
Cerebral Arteries;
Glycosaminoglycans;
Head;
Headache;
Headache Disorders, Primary;
Humans;
Magnetic Resonance Angiography;
Neurologic Manifestations;
Nimodipine;
Seizures;
Stroke;
Takayasu Arteritis;
Vascular Diseases;
Vasoconstriction
- From:Journal of Rheumatic Diseases
2013;20(3):194-197
- CountryRepublic of Korea
- Language:English
-
Abstract:
Takayasu's arteritis (TA) is a chronic inflammatory vascular disease that mainly affects large vessels. Central nervous system involvement occurs in about 20% of cases with rare involvement of intracranial vessel, and its typical manifestation is cerebral ischemia or stroke. Reversible cerebral vasoconstriction syndrome (RCVS) is a group of disorders with prolonged, but reversible vasoconstriction of the cerebral arteries with acute-onset, severe, recurrent headaches with or without neurologic signs or symptoms. We report a case of TA in a 17-year old girl who presented with secondary RCVS. She complained of thunderclap headache, seizure and acute stroke. 3-dimensional computed tomography scan and magnetic resonance angiography of head revealed irregular thickening of aortic wall and its main branches with multifocal narrowing of intracranial basilar artery, which improved after oral nimodipine intake. This case highlights RCVS as an unusual manifestation of TA and demonstrates the diagnosis, treatment and response to therapy of RCVS in TA, which resolved after treatment with calcium channel blocker.
